Fetal Rat Myoblasts Release Both Rat Somatomedin-C (SM-C)/Insulin-Like Growth Factor I (IGF I) and Multiplication-Stimulating Activityin Vitro: Partial Characterization and Biological Activity of Myoblast-Derived SM-C/IGF I*
- 1 November 1985
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 117 (5) , 2061-2072
- https://doi.org/10.1210/endo-117-5-2061
Abstract
The relative release of rat somatomedin-C (SM-C)/insulin-like growth factor I (IGF I) and multiplication-stimulating activity (MSA) immunoreactivity and bioactivity from isolated fetal rat myoblasts was assessed by a partial characterization of the SM peptides present in concentrated myoblast-conditioned culture medium (MCM). The SM bioactivity of MCM, measured by [3H]thymidine or [35S]sulfate uptake by fetal rat cartilage explants, eluted with an apparent size of 50-80K on Sephadex G-200 at pH 7.5, and was associated with SM-C/IGF I immunoreactivity. Chromatography of MCM on Bio-Gel P-10 or Sephadex G-75 at acidic pH resulted in a peak of SM bioactivity associated with both SM-C/IGF I and MSA immunoreactivity in the 6-9K region. SM-binding activity, measured by competition with activated charcoal for [125I]SM-C or MSA, eluted in the void volume. When these fractions were incubated with [125I]SM-C and chromatographed on Sephadex G-200 at neutral pH, a heterogeneous pattern of binding proteins was seen, with a major component of 50-80 K. After chromatofocusing of proteins in the 6-9 K region from Bio-Gel P-10, three peaks of SM bioactivity were recovered, each associated with SM-C immunoreactivity, with pI values of 8.5, 7.1, and 6.5. Although both the basic and neutral peaks enhanced [3H]thymidine uptake by growth-restricted fetal rat myoblasts in vitro, only the bioactivity of the former could be blocked by incubation with a monoclonal antibody to human SM-C. Both human SM-C/IGF I and MSA purified from Buffalo rat liver cell-conditioned medium enhanced thymidine incorporation by growth-restricted fetal rat myoblasts. The results suggest that unlike reports of other fetal rat tissues, fetal rat tissues, fetal rat myoblasts released approximately equal amounts of rat SM-C/IGF I and MSA during culture. The myoblast-derived SM-C/IGF I was biologically active on the cell type of origin and may play a paracrine role in muscle development.This publication has 12 references indexed in Scilit:
- Inhibition of the mitogenic effects of plasma by a monoclonal antibody to somatomedin C.Proceedings of the National Academy of Sciences, 1984
- Synthesis of Multiplication-Stimulating Activity (Rat Insulin-Like Growth Factor II) by Rat Embryo Fibroblasts*Endocrinology, 1983
- Increased thymidine incorporation into fetal rat cartilage in vitro in the presence of human somatomedin, epidermal growth factor and other growth factorsJournal of Endocrinology, 1983
- Developmental Pattern of a Serum Binding Protein for Multiplication Stimulating Activity in the RatJournal of Clinical Investigation, 1982
- Measurement of Somatomedin-Related Peptides in Fetal, Neonatal, and Maternal Rat Serum by Insulin-Like Growth Factor (IGF) I Radioimmunoassay, IGF-II Radioreceptor Assay (RRA), and Multiplication- Stimulating Activity RRA after Acid-Ethanol Extraction*Endocrinology, 1982
- Inhibition of Access of Bound Somatomedin to Membrane Receptor and Immunobinding Sites: A Comparison of Radioreceptor and Radioimmunoassay of Somatomedin in Native and Acid-Ethanol-Extracted Serum*Journal of Clinical Endocrinology & Metabolism, 1980
- Ontogeny of somatomedin during development in the mouseDevelopmental Biology, 1980
- Characterization of a somatomedin (insulin-like growth factor) synthesized by fetal rat liver organ cultures.Journal of Biological Chemistry, 1979
- PARTIAL PURIFICATION AND CHARACTERIZATION OF A BINDING PROTEIN FOR INSULIN-LIKE ACTIVITY (ILAs) IN HUMAN AMNIOTIC FLUID: A POSSIBLE INHIBITOR OF INSULIN-LIKE ACTIVITYActa Endocrinologica, 1979
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951